Brief: Summit Therapeutics Raises $500 Million in Private Placement
22/10/2025 13:12
Oct 22 (Reuters) - Summit Therapeutics Inc SMMT.O: SUMMIT THERAPEUTICS RAISES $500 MILLION IN PRIVATE PLACEMENT SUMMIT THERAPEUTICS INC - TO USE PROCEEDS FOR IVONESCIMAB DEVELOPMENT SUMMIT THERAPEUTICS INC: FUNDRAISE LED BY LEADING BIOPHARMA INSTITUTIONAL INVESTORS & INSIDERS Source text: ID:nBwHDhz0a Further company coverage: SMMT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Summit Therapeutics
See all newsBrief: Akeso Announces Summit Therapeutics And Ecog-Acrin Cancer Research Group Enter Into Phase Ii/Iii Clinical Trial Collaboration To Evaluate Ivonescimab In First-Line Biliary Tract Cancer
Factbox: Major drugmakers turn to China for licensing deals
Brief: Summit Therapeutics Announces Opening Of Global Phase Ii Study Of Ivonescimab-Based Regimens In Advanced Clear Cell Renal Cell Carcinoma
Factbox: Major drugmakers turn to China for licensing deals
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination (updated)